Angela C. Weyand, MD

Associate Professor
University of Michigan

Presentation(s):

• LB 01.4 - Efficacy, Safety, and Pharmacokinetics of Once-Weekly Efanesoctocog Alfa (BIVV001) Prophylaxis in Previously Treated Patients With Severe Hemophilia A: Results From the Phase 3 XTEND-1 Study

  Sunday, July 10, 2022
  3:30 PM – 3:45 PM

• SSC 19.05 - Risk of Thrombosis with Tranexamic acid and Combined Oral Contraceptives (SSC Project) 

  Tuesday, July 12, 2022
  5:10 PM – 5:20 PM